# Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma

> **NCT07346404** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 50 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** 82-Rb injection

## Key facts

- **NCT ID:** NCT07346404
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07346404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07346404, "Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07346404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
